EGFR and lung adenocarcinoma: For tumor subtyping, it distinguishes lung adenocarcinoma (textural heterogeneity, AUC 0.80) from squamous cell carcinoma on CT and predicts EGFR mutations (75% accuracy) via ground-glass opacity patterns.